Scott Dreyer

EVP & Chief Commercial Officer, Collegium Pharmaceutical

Bought, 12 months

$0.0M

Sold, 12 months

$2.9M

Companies

Latest trade

Mar 3, 2026

Companies

Collegium PharmaceuticalEVP & Chief Commercial Officer −$2.9M

Trades

COLL Sold 49,976 shares at $40.40 · planned $2.0M Mar 3

COLL Sold 17,600 shares at $48.17 · planned $0.8M Dec 8

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.